Don’t Miss Out on the Latest Updates.
Subscribe to Our Newsletter Today!
Mindfulness is a meditation technique lauded by many for its effects on one's well being and productivity. Mindfulness is all about being focussed on the present moment, which has the power to liberate one from the shackles of past failures or pointless day dreaming about the future. It's is obvious that it has various health benefits from improving your concentration to relieve you from stress. Complementing its benefits, a new study claims that it can also cure recurrent depression. (Read:Women listen up -- mindfulness more effective in weight loss )
Mindfulness-based cognitive therapy (MBCT) could provide an alternative non-drug treatment for people who do not wish to continue long-term antidepressant treatment. The results come from the first ever large study to compare MBCT - structured training for the mind and body which aims to change the way people think and feel about their experiences, with maintenance antidepressant medication for reducing the risk of relapse in depression. (Read: Beat stress with mindful meditation)
The study aimed to establish whether MBCT was superior to maintenance antidepressant treatment in terms of preventing relapse of depression. Although the findings showed that MBCT wasn't any more effective than maintenance antidepressant treatment in preventing relapse of depression, the results, combined with those of previous trials, suggested that MCBT might offer similar protection against depressive relapse or recurrence for people who have experienced multiple episodes of depression , with no significant difference in cost. (Read: Mindfulness meditation or Vipassana -- a beginner's guide)
Professor Sarah Byford, from the Institute of Psychiatry, Psychology and Neuroscience (IoPPN) at King's College London, said that as a group intervention, mindfulness-based cognitive therapy was relatively low cost compared to therapies provided on an individual basis and, in terms of the cost of all health and social care services used by participants during the study, they found no significant difference between the two treatments.
The study is published in The Lancet.
With inputs from ANI
Image source: Getty Images
For more articles on diseases & conditions, visit our diseases & conditions section. For daily free health tips, sign up for our newsletter.